Population Pharmacokinetic Modeling and Simulation of Quetiapine in Chinese Psychiatric Patients for Individualized Dosing and Missed-Dose Management
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-14
DOI: 10.2147/dddt.s626667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Yuqing Li und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Psychiatrische Pflege, Simulation in der Pflegeausbildung
Abstract (Originalsprache)
Objective
To develop a population pharmacokinetic (PPK) model for quetiapine using real-world therapeutic drug monitoring (TDM) data from psychiatric patients, evaluate the influence of demographic characteristics, pharmacogenetic factors, and concomitant medications on quetiapine pharmacokinetics, and develop model-informed remedial dosing strategies for missed-dose scenarios.
Methods
A retrospective PPK analysis was conducted using TDM data from patients receiving quetiapine. Population pharmacokinetic analysis was performed using nonlinear mixed-effects modeling (NONMEM). Demographic variables, CYP2D6 polymorphisms, and concomitant medications were evaluated as candidate covariates. Model performance was assessed using goodness-of-fit plots, bootstrap analysis, and normalized prediction distribution errors (NPDE). Model simulations were performed to evaluate quetiapine exposure in representative patient populations and to investigate remedial dosing strategies following delayed or missed doses.
Results
A total of 986 TDM concentrations from 210 psychiatric patients were included. Quetiapine pharmacokinetics were described by a one-compartment model with first-order absorption and elimination. The estimated apparent clearance (CL/F) and apparent volume of distribution (V/F) were 107 L/h and 2090 L, respectively. Age and concomitant sertraline use were retained as significant covariates during the predefined covariate modeling procedure. Model simulations suggested that these covariates influenced quetiapine exposure profiles. Missed doses resulted in rapid declines in serum concentrations below the selected therapeutic reference range, whereas model-informed remedial dosing strategies improved target attainment while limiting excessive concentration fluctuations.
Conclusion
A population pharmacokinetic model describing quetiapine pharmacokinetics in psychiatric patients was successfully developed using real-world TDM data. Model-informed simulations suggest that this framework may support individualized dose optimization and the evaluation of remedial dosing strategies following missed doses.
Zitieren
APA
Li, Y., Huang, S., Lu, H., Xia, H., Yan, H., Huang, W., Yan, X., Zhang, M., Xia, S., & Shang, D. (2026). Population Pharmacokinetic Modeling and Simulation of Quetiapine in Chinese Psychiatric Patients for Individualized Dosing and Missed-Dose Management. Drug Design, Development and Therapy, Volume 20, 1-14. https://doi.org/10.2147/dddt.s626667
Vancouver
Li Y, Huang S, Lu H, Xia H, Yan H, Huang W, et al. Population Pharmacokinetic Modeling and Simulation of Quetiapine in Chinese Psychiatric Patients for Individualized Dosing and Missed-Dose Management. Drug Design, Development and Therapy. 2026;Volume 20:1-14. doi:10.2147/dddt.s626667
BibTeX
@article{Li2026,
author = {Li, Yuqing and Huang, Shanqing and Lu, Haoyang and Xia, Hui and Yan, Hui and Huang, Wanting and Yan, Xiaoyu and Zhang, Ming and Xia, Shiyong and Shang, Dewei},
title = {Population Pharmacokinetic Modeling and Simulation of Quetiapine in Chinese Psychiatric Patients for Individualized Dosing and Missed-Dose Management},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--14},
doi = {10.2147/dddt.s626667}
}
EUVIMED